Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Zealand Pharma A/S ADR (ZEAL)

15.4 -0.2 (-1.28%)

05-25 16:00

Open:

15.54

Pre. Close:

15.6

High:

15.54

Low:

15.4

Volume:

4,193

Market Cap:

448M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

15.547 - 15.651

15.651 - 15.738

Low:

15.197 - 15.3

15.3 - 15.386

Close:

15.25 - 15.416

15.416 - 15.554

Technical analysis  (as of: 2018-05-25 4:41:00 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 22.50     One year: 25.77

Support:

Support1: 14.75    Support2: 12.27

Resistance:

Resistance1: 19.27    Resistance2: 22.06

Pivot:

16.24

Moving Averages:

MA(5): 16.00     MA(20): 15.98

MA(100): 15.61     MA(250):

MACD:

MACD(12,26): 0.24     Signal(12,26,9): 0.31

%K %D:

%K(14,3): 11.87     %D(3): 16.01

RSI:

RSI(14): 47.71

52-Week:

High: 20.37  Low: 12.45  Change(%): 5.3

Average Vol(K):

3-Month: 1691  10-Days 894

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ZEAL has closed above bottom band by 36.9%. Bollinger Bands are 179.7% wider than normal. The large width of the bands suggest high volatility as compared to ZEAL's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-04-11T08:50:47-04:00
Zealand teams up with Roche in late-stage studies of hyperinsulinism candidate dasiglucagon

2018-03-24T01:01:19-04:00
Biotech Analysis Central Pharma News: Regeneron And Alnylam Team Up, Zealand's Rescue Pen Succeeds, AbbVie's Hope Remains With Rova-T Prospects

2018-02-09T07:54:39-05:00
ROTY Edition 1 Volume 77: Market Turmoil Continues - How To React

2018-02-06T11:42:23-05:00
ROTY Edition 1 Volume 76: How To Deal With Market Selloffs And Spring Cleaning For The Contenders List

2018-02-03T08:45:32-05:00
Stocks To Watch: Welcome To The Party Rising Rates

2018-02-02T10:50:57-05:00
ROTY Edition 1 Volume 75: The Future Of ROTY, Cascadian Acquired And Updates

2018-01-30T11:51:02-05:00
ROTY Edition 1 Volume 74: A New Feature For Readers, Updates And Trades

2018-01-25T06:21:35-05:00
ROTY Edition 1 Volume 73: New Features And A Controversial Swap Out

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

30.69

Shares Float (M)

30.69

% Held by Insiders

% Held by Institutions

9.00

Shares Short (K)

255

Shares Short Prior Month (K)

196

Stock Financials

EPS

-1.350

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

6.270

PEG Ratio

Profit Margin

Operating Margin

-176.27

Return on Assets (ttm)

-40.4

Return on Equity (ttm)

-75.7

Qtrly Rev. Growth

-93.8

Gross Profit (p.s.)

0.560

Sales Per Share

EBITDA (p.s.)

-0.675

Qtrly Earnings Growth

Operating Cash Flow (M)

-45.96

Levered Free Cash Flow (M)

-24.18

atoplab.com

Valuation

P/E

-11.41

P/E Growth Ratio

-0.01

P/BV

2.46

P/S

528424096.00

P/CF

-10.28

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.